• 1.

    Beck LH Jr, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:1121. doi: 10.1056/NEJMoa0810457

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Meyer-Schwesinger C, et al. A novel mouse model of phospholipase A2 receptor 1-associated membranous nephropathy mimics podocyte injury in patients [Published online ahead of print November 07, 2019]. doi: 10.1016/j.kint.2019.10.022.

    • Search Google Scholar
    • Export Citation
  • 3.

    Stanescu HC, et al. Risk HLA-DQA1 and PLA2R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011; 364:616626. doi: 10.1056/NEJMoa1009742

  • 4.

    Zang X, et al. The genetic and environmental factors of primary membranous nephropathy: An overview from China. Kidney Dis (Basel). 2018; 4:6573. doi: 10.1159/000487136

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Fresquet M, et al. Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy. J Am Soc Nephrol 2015; 26:302313. doi: 10.1681/ASN.2014050502

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Seitz-Polski B, et al. Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy. J Am Soc Nephrol 2016; 27:15171533. doi: 10.1681/ASN.2014111061

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Reinhard L, et al. Clinical relevance of domain-specific phospholipase A2 receptor 1 antibody levels in patients with membranous nephropathy. J Am Soc Nephrol 2020; 31:197207. doi: 10.1681/ASN.2019030273

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Beck LH Jr, et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 2011; 22:15431550. doi: 10.1681/ASN.2010111125

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Tomas NM, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 2014; 371:22772287. doi: 10.1056/NEJMoa1409354

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Herwig J, et al. Thrombospondin type 1 domain-containing 7A localizes to the slit diaphragm and stabilizes membrane dynamics of fully differentiated podocytes. J Am Soc Nephrol 2019; 30:824839. doi: 10.1681/ASN.2018090941

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Hoxha E, et al. A mechanism for cancer-associated membranous nephropathy. N Engl J Med 2016; 374:19951996. doi: 10.1056/NEJMc1511702

  • 12.

    Hoxha E, et al. An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy. J Am Soc Nephrol 2017; 28:520531. doi: 10.1681/ASN.2016010050

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Sethi S, et al. Exostosin 1/exostosin 2-associated membranous nephropathy. J Am Soc Nephrol 2019; 30:11231136. doi: 10.1681/ASN.2018080852

  • 14.

    Sethi S, et al. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int 2020; 97:163174. doi: 10.1016/j.kint.2019.09.014

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Xu X, et al. Long-term exposure to air pollution and increased risk of membranous nephropathy in China. J Am Soc Nephrol 2016; 27:37393746. doi: 10.1681/ASN.2016010093

    • Crossref
    • Search Google Scholar
    • Export Citation

Discovery of PLA2R: 10-Year Anniversary of a Milestone for Idiopathic Membranous Nephropathy

Restricted access
Save